Time is of the essence in drug development. This video will equip you with the essential knowledge to navigate the nonproprietary naming process for branding your Phase 1 and 2 assets. Watch to:
- Understand the INN and USAN review processes.
- Identify the proper steps in designing the most appropriate generic naming strategy for your asset.
- Learn where to find the applications online for an INN or USAN.
- Learn how best to start the 10-step process for your asset.
Download the presentation from the video here: https://go.brandsymbol.com/l/1020922/2024.
Want to learn more? Reach out to us for a virtual coffee: https://brandsymbol.com/contact/. ☕
If you’re unsure what a nonproprietary name is, it’s also commonly referred to as a generic name or USAN/INN name. This name is required for any new compound and is typically assigned while the drug is in the early to mid-phase of its clinical trials. It classifies the drug’s pharmacological characteristics and becomes the universal standard for referring to the drug compound regardless of its manufacturer or product brand